Related Experiment Video
Updated: Oct 19, 2025
13:34
Assessment of Memory Function in Pilocarpine-induced Epileptic Mice
Published on: June 4, 2020
8.5K
Cannabidiol (CBD) and cognition in epilepsy.
Tyler E Gaston1, Roy C Martin2, Jerzy P Szaflarski3
1Department of Neurology and the UAB Epilepsy Center, University of Alabama at Birmingham, Birmingham, AL, USA; Veteran's Administration Medical Center, Birmingham, AL, USA.
Epilepsy & Behavior : E&B
|September 26, 2021
Summary
Cannabidiol (CBD) shows promise for improving cognition in epilepsy patients beyond seizure control. Research explores CBD
Area of Science:
- Neuroscience
- Pharmacology
- Epilepsy Research
Background:
- Epilepsy is frequently accompanied by cognitive impairment, stemming from seizures, anti-seizure medications (ASMs), and mood issues.
- Cannabidiol (CBD) is FDA-approved for epilepsy treatment and possesses unique neuroprotective and anti-inflammatory properties.
- Understanding CBD's cognitive effects is crucial for patient care and treatment selection.
Purpose of the Study:
- To review current data on cannabidiol's (CBD) effects on cognition in epilepsy.
- To explore proposed mechanisms of CBD's cognitive actions.
- To summarize pre-clinical and human study findings on CBD and cognition in epilepsy.
Main Methods:
- Review of existing literature on CBD and cognition in epilepsy.
- Analysis of pre-clinical/animal studies in epilepsy models.
- Examination of human clinical trials assessing cognitive function in epilepsy patients on CBD.
Main Results:
- CBD exhibits neuroprotective, anti-inflammatory, antioxidant, and neurogenesis effects.
- Pre-clinical data suggest potential cognitive benefits of CBD in epilepsy models.
- Human studies are investigating CBD's impact on cognitive function and brain structure in epilepsy.
Conclusions:
- Cannabidiol (CBD) may offer cognitive benefits in epilepsy independent of seizure control.
- Further research is needed to fully elucidate CBD's role in managing epilepsy-related cognitive impairment.
- CBD's multifaceted mechanisms of action warrant investigation for broader therapeutic applications in neurological disorders.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
369
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
369
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
808
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
808
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
241
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
241
01:20Antiepileptic Drugs: Potassium Channel Activators
363
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
363
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
527
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
527
01:14Antiepileptic Drugs: Glutamate Antagonists
595
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
595